We are live on ! Find out more
GCM

Gables Capital Management Portfolio holdings

AUM $236M
1-Year Est. Return 32.91%
This Fund
S&P 500
This Quarter Est. Return
+13.56%
1 Year Est. Return
+32.91%
3 Year Est. Return
+123.38%
5 Year Est. Return
+165.74%
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$12.8M
Cap. Flow
-$1.48M
Cap. Flow %
-1.08%
Top 10 Hldgs %
32.96%
Holding
369
New
24
Increased
15
Reduced
94
Closed
9

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$489K
2
MELI icon
Mercado Libre
MELI
+$89K
3
RXO icon
RXO
RXO
+$75.6K
4
NVO
Novo Nordisk
NVO
+$70.4K
5
JEPI icon
JPMorgan Equity Premium Income ETF
JEPI
+$59.5K

Top Sells

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$173K
2
AAPL icon
Apple
AAPL
+$149K
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$144K
4
NVDA icon
NVIDIA
NVDA
+$139K
5
CVX icon
Chevron
CVX
+$122K

Sector Composition

Rank Sector Weight
1 Healthcare 14.32%
2 Financials 13.98%
3 Technology 13.68%
4 Consumer Discretionary 12.02%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
151
Texas Instruments
TXN
$259B
$93.3K 0.07%
565
– –
OTIS icon
152
Otis Worldwide
OTIS
$28B
$92K 0.07%
1,175
– –
SCI icon
153
Service Corp International
SCI
$11.7B
$90.7K 0.07%
1,312
– –
MDY icon
154
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
$88.6K 0.06%
200
– –
LPLA icon
155
LPL Financial
LPLA
$27.9B
$86.5K 0.06%
400
– –
LRCX icon
156
Lam Research
LRCX
$398B
$85.7K 0.06%
2,040
– –
RIO icon
157
Rio Tinto
RIO
$161B
$85.4K 0.06%
1,200
– –
MELI icon
158
Mercado Libre
MELI
$95.7B
$84.6K 0.06%
+100
New +$89K
AVGO icon
159
Broadcom
AVGO
$1.99T
$83.3K 0.06%
1,490
– –
NVO
160
Novo Nordisk
NVO
$196B
$81.2K 0.06%
+1,200
New +$70.4K
TTE icon
161
TotalEnergies
TTE
$189B
$80.7K 0.06%
1,300
– –
CFR icon
162
Cullen/Frost Bankers
CFR
$10.5B
$80.2K 0.06%
600
– –
RGLD icon
163
Royal Gold
RGLD
$17.5B
$78.9K 0.06%
700
– –
AMP icon
164
Ameriprise Financial
AMP
$48.9B
$77.8K 0.06%
250
– –
WFC icon
165
Wells Fargo
WFC
$267B
$74.3K 0.05%
1,800
– –
CGC
166
Canopy Growth
CGC
$393M
$73.6K 0.05%
3,185
-85
-3% -$2.62K
EXC icon
167
Exelon
EXC
$47.2B
$73.5K 0.05%
1,700
-100
-6% -$3.95K
RXO icon
168
RXO
RXO
$3.65B
$73.3K 0.05%
+4,260
New +$75.6K
PNC icon
169
PNC Financial Services
PNC
$101B
$73K 0.05%
462
– –
DOCU
170
DocuSign
DOCU
$11B
$72.2K 0.05%
1,302
-590
-31% -$28.7K
OTLK icon
171
Outlook Therapeutics
OTLK
$180M
$71.8K 0.05%
3,325
+250
+8% +$5.44K
WASH icon
172
Washington Trust Bancorp
WASH
$761M
$70.8K 0.05%
1,500
– –
SPOT icon
173
Spotify
SPOT
$98.3B
$67.5K 0.05%
855
-170
-17% -$13.7K
QCOM icon
174
Qualcomm
QCOM
$171B
$67.3K 0.05%
612
– –
RYN icon
175
Rayonier
RYN
$6.6B
$65.9K 0.05%
2,204
– –
5 6
7
8 9

Similar funds

CWL
Causey Wealth LLC Greenwood Village, Colorado $236M AUM 14.5% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
CF
CNA Financial Chicago, Illinois $235M AUM 3.39% 1-Year Est. Return
BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Gables Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Gables Capital Management held 369 positions worth $137M, up 10% from $125M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gables Capital Management's Q4 2022 filing shows 24 new, 15 increased, 94 reduced and 9 closed positions. Its largest new stake was Mercado Libre: 100 shares worth $84.6K. The largest sale was Catalyst Pharmaceutical, an estimated $173K.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Gables Capital Management's largest Q4 2022 buy was Mercado Libre: 100 shares worth $84.6K.
  • Gables Capital Management added most to Walt Disney in Q4 2022, an estimated $489K increase.
  • Gables Capital Management's biggest Q4 2022 reduction was Catalyst Pharmaceutical, cutting an estimated $173K.
  • Gables Capital Management fully exited Cleveland-Cliffs in Q4 2022, selling an estimated $40K.
  • Gables Capital Management's ten largest holdings make up 33% of its $137M portfolio in Q4 2022.
  • Gables Capital Management opened 24 new positions and closed 9 in Q4 2022.
  • Gables Capital Management's portfolio value rose 10% quarter-over-quarter to $137M.

Based on Gables Capital Management's 13F filing for Q4 2022, filed 6 Feb 2023.